<DOC>
	<DOCNO>NCT00610259</DOCNO>
	<brief_summary>The purpose study examine effectiveness brief behavioral therapy insomnia ( bBT-I ) addition treatment usual ( TAU ) comparison TAU alone refractory insomnia among patient major depression partial remission .</brief_summary>
	<brief_title>Brief Behavioral Therapy Insomnia ( bBT-I ) Depressed Outpatients With Refractory Insomnia</brief_title>
	<detailed_description />
	<mesh_term>Depressive Disorder</mesh_term>
	<mesh_term>Depression</mesh_term>
	<mesh_term>Sleep Initiation Maintenance Disorders</mesh_term>
	<mesh_term>Depressive Disorder , Major</mesh_term>
	<criteria>1 . DSMIV major depressive disorder , ascertain Structured Clinical Interview DSMIV Axis I disorder ( SCID ) 2 . Either sex , 20 70 year age time entry trial 3 . Outpatient time entry trial 4 . For index episode , patient already two type adequate dos antidepressant shorter 4 week medication already two type antidepressant 8 week total even dose drug adequate due side effect . The medication change least 4 week prior study entry . 5 . A score 2 least one three sleep item 17GRIDHAMD score 8 ISI . 6 . A score 8 23 17GRIDHAMD . 7 . Agreement requirement ) change medication allow first 4 week study period , ii ) treatment session bBTI TAU audiotaped purpose check adherence protocol 1 . Their mental physical status time entry trial regard critical need immediate hospitalisation 2 . A serious suicidal risk , define score 3 item 3 ( suicidal ideation ) 17GRIDHAMD 3 . Patients structure psychotherapy ( e.g . cognitive therapy , family therapy ) time entry 4 . Patients current diagnosis primary anxiety personality disorder , insomnia associate another sleep disorder , significant medical problem , current drug alcohol substance abuse dependence , psychosis , history schizophrenia bipolar disorder 5 . Patients duration depression shorter 2 month 6 . Their insomnia consider derive sleep apnoea periodic limb movement sleep , judged clinician . 7 . Patients engage work involve nightshift , might influence sleep status 8 . Patients currently take methylphenidate modafinil .</criteria>
	<gender>All</gender>
	<minimum_age>20 Years</minimum_age>
	<maximum_age>70 Years</maximum_age>
	<verification_date>September 2009</verification_date>
	<keyword>Depressive disorder</keyword>
	<keyword>Sleep initiation maintenance disorder</keyword>
	<keyword>Behavior therapy</keyword>
</DOC>